Patents by Inventor Eric Dumas De La Roque

Eric Dumas De La Roque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CATHETER COMPRISING A SPRAYING DEVICE AND A CONTROL UNIT
    Publication number: 20230011654
    Abstract: A catheter for delivering a medicinal liquid or a powder in spray form into the trachea of a subject, includes a deformable body including a spray device for expelling a liquid or a powder introduced into the catheter as a spray, the body of the catheter being configured to generate an image of a zone in a longitudinal direction of the body.
    Type: Application
    Filed: December 18, 2020
    Publication date: January 12, 2023
    Inventors: Eric DUMAS DE LA ROQUE, Michael FAYON
  • MASK FOR ARTIFICIAL VENTILATION OF A PATIENT
    Publication number: 20190240441
    Abstract: The invention relates to a mask (100) for the mechanical ventilation of a patient, comprising: a mask body made of flexible material, comprising a ventilation chamber (103), said mask body being provided with means (105) for connection to a respirator, and adhesive and gas-tight attachment means (10), comprising a peripheral edge (11) secured to the mask body and intended to surround at least the patient's nostrils, in order to hold in a tight manner the ventilation chamber at least around patient's nostrils.
    Type: Application
    Filed: October 13, 2017
    Publication date: August 8, 2019
    Inventor: ERIC DUMAS DE LA ROQUE
  • Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
    Patent number: 9173858
    Abstract: The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: November 3, 2015
    Assignees: Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux
    Inventors: Christine Leaute-Labreze, Eric Dumas De La Roque, Alain Taieb, Jean-Benoit Thambo
  • Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
    Patent number: 8987262
    Abstract: The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroïds, interferon or vincristine, generally used for the treatment of hemangiomas.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: March 24, 2015
    Assignees: Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux
    Inventors: Christine Leaute-Labreze, Eric Dumas De La Roque, Alain Taieb, Jean-Benoit Thambo
  • Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
    Patent number: 8338489
    Abstract: The present disclosure relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present disclosure provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: December 25, 2012
    Assignee: Université Victor Segalen—Bordeaux 2
    Inventors: Christine Léauté-Labrèze, Éric Dumas De La Roque, Alain Taieb, Jean-Benoît Thambo